Physician profile
Ahmed A Romeya
NPI 1598834186
$144,682.58
in general payments reported to CMS, 2019-2025
22 companies · $17K in 2025
The $17K reported for 2025 was more than what 93% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $2,061 · 2021: $12K · 2022: $5,239 · 2023: $32K · 2024: $61K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $89K · Travel and Lodging: $16K · Food and Beverage: $5,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $88,750.00 |
| Travel and Lodging | $15,781.24 |
| Food and Beverage | $5,201.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $135,163.95 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Medtronic Vascular, INC. | $3,458.62 | 2019-2020 | |
| Angiodynamics, INC. | $2,931.44 | 2022-2025 | Angiovac |
| Artivion, INC. | $975.42 | 2025 | Amds-Ascyrus Medical |
| Abiomed | $613.71 | 2021-2024 | Impella |
| Edwards Lifesciences Corporation | $345.59 | 2019-2023 | Sapien 3 Ultra Resilia |
| Body Vision Medical INC. | $229.35 | 2023 | Lungvision |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $165.35 | 2022-2023 | Lifevest |
| Medtronic, INC. | $152.85 | 2021-2025 | Corevalve Evolut R, Na |
| Boston Scientific Corporation | $142.59 | 2019 | |
| Microtransponder, INC. | $94.63 | 2024 | |
| Haemonetics Corporation | $94.21 | 2021 | |
| Abbott Laboratories | $52.54 | 2020-2021 | |
| Novo Nordisk INC | $41.34 | 2023-2025 | Ozempic, Wegovy |
| Zimmer Biomet Holdings, INC. | $41.00 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $40.94 | 2020-2025 | Neoview |
| Bard Access Systems, INC. | $34.71 | 2019 | |
| Genentech USA, INC. | $29.50 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $22.94 | 2023 | |
| Pfizer INC. | $21.15 | 2023 | |
| Cvrx, INC. | $16.23 | 2022 | |
| Aesculap, INC. | $14.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Romeya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.